Skip to content

Becton Dickinson & Co

US · BDX #450 by market cap Listed 1970
212.78 +0.10 +0.05%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions decreased by 5 in the most recent period (2026/Q4).
  • Total institutional ownership (as a % of shares) was little changed.

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
97.28% -0.09pp
Institutions
1,769 -5
As of
2026/Q4 vs. prior period

Holder types

Mutual Fund83.73%
Public Company3.43%
Hedge Fund2.65%
Private Company2.39%
Government Pension Fund1.97%
Sovereign Wealth Fund1.58%
Insurance Company0.77%
Family Office/Trust0.28%
Individual/Insider0.17%
Other3.03%

Top holders as of 2026-09-30

BlackRock 8.67% · 23.62M sh
Vanguard Capital Management, LLC 7.11% · 19.36M sh
State Street Global Advisors 5.58% · 15.21M sh
Vanguard Portfolio Management, LLC 5.40% · 14.70M sh
First Eagle Investment Management, LLC 5.10% · 13.88M sh
Geode Capital Management, LLC 2.97% · 8.09M sh
Invesco Ltd. 2.72% · 7.40M sh
Putnam LLC 2.65% · 7.22M sh
MFS Investment Management 2.49% · 6.78M sh
T. Rowe Price Group, Inc. 2.40% · 6.54M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 25 buys · 20 sells

NameRoleStake
Thomas Polen Chairperson & CEO 0.04%
Timothy Ring Independent Director 0.02%
Bilal Muhsin Executive VP & President of Future Connected Care Segment 0.02%
Bertram Scott Independent Director 0.01%
Christopher Ian Jones Independent Director 0.01%
Shana Neal Former Chief Human Resources Officer 0.01%
Michael Feld Chief Revenue Officer 0.01%
Christopher DelOrefice Former Chief Financial Officer 0.01%
Roland Goette Former Executive VP & President of EMEA 0.01%
Michael Garrison Former Executive VP & President of Medical Segment and BioPharma Systems Segments 0.00%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-11-05 Robert Huffines Independent Director Other Derivative Acquisition +158 --
2026-11-05 Carrie Byington Independent Director Other Derivative Acquisition +79 --
2026-11-04 Thomas Polen Chairperson & CEO Derivative Exercise and Sale -20,239 $178.94–210.00
2026-10-25 Michael Feld Chief Revenue Officer Automatic Disposition -76 $198.13
2026-09-27 Michael Feld Chief Revenue Officer Automatic Disposition -76 $183.70
2026-09-01 vitor Roque Chief Financial Officer Sale to Issuer -190 --
2026-08-25 Michael Feld Chief Revenue Officer Automatic Disposition -165 $188.49
2026-08-19 Michael Feld Chief Revenue Officer Sale to Issuer -1,049 --
2026-08-12 Thomas Polen Chairperson & CEO Derivative Exercise and Sale -43,278 $167.25–185.00
2026-08-10 Roland Goette Former Executive VP & President of EMEA Open Market Disposition -2,438 $180.84
2026-08-05 Robert Huffines Independent Director Other Derivative Acquisition +189 --
2026-08-05 Carrie Byington Independent Director Other Derivative Acquisition +94 --
2026-07-26 Michael Feld Chief Revenue Officer Automatic Disposition -75 $157.13
2026-07-01 Bilal Muhsin Executive VP & President of Future Connected Care Segment Sale to Issuer -1,935 --
2026-06-30 Bilal Muhsin Executive VP & President of Future Connected Care Segment Other Acquisition +14,342 --
2026-06-25 Michael Feld Chief Revenue Officer Automatic Disposition -75 $152.80
2026-06-23 Michael Garrison Former Executive VP & President of Medical Segment and BioPharma Systems Segments Automatic Disposition -1,100 $145.66
2026-06-21 Manish Sinha Executive Vice President Initial Statement of Beneficial 0 --
2026-06-09 Michael Garrison Former Executive VP & President of Medical Segment and BioPharma Systems Segments Automatic Disposition -1,100 $151.48
2026-05-31 Thomas Polen Chairperson & CEO Derivative Exercise and Sale -20,209 $126.16–146.35

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Becton Dickinson & Co discussion 0 comments

Add a comment